In summary, increase in BCAA, serum β-amyloid, LPS, tau, curli protein, E.coli, and a low minimental score were significantly associated with dementia followed by mild cognitive impairment (Figure 6A,B), indicating that these parameters can be used as biomarkers to detect mild cognitive impairment or dementia. This evidence concerns the gene MAPT and dementia.